Cliquez pour voir le graph
			
				
				Connexions
			
		Cliquez pour voir la ligne de temps
			
				
				Ligne de temps
			
		Projets
Publications
Télécharger- 
													
	2025Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms., RMD Open 2025 Jul; 11(3): .
- 
													
	2025Structural basis for hepatitis E virus neutralization by potent human antibodies., Sci Adv 2025 May; 11(19): eadu8811.
- 
													
	2024Enhanced hepatitis B virus-specific immunity by combining neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B virus infection., Hepatology 2024 Dec; (): .
- 
													
	2024Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
- 
													
	2024Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells., Nat Commun 2024 Jan; 15(1): 178.
- 
													
	2024Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies., Pathog Immun 2024 ; 10(1): 1-11.
- 
													
	2023High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1., J Virol 2023 Dec; (): e0135123.
- 
													
	2023TMPRSS2 is a functional receptor for human coronavirus HKU1., Nature 2023 Dec; 624(7990): 207-214.
- 
													
	2023SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells., Nat Immunol 2023 Nov; (): .
- 
													
	2023HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteria., Nat Commun 2023 Oct; 14(1): 6326.
- 
												
													+Voir la liste complète de publications
 
														 
																	 
			
		 
			
		 
							 
							
